Edwards Lifesciences Corporation

Informe acción NYSE:EW

Capitalización de mercado: US$51.7b

Edwards Lifesciences Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Bernard Zovighian

Chief Executive Officer (CEO)

US$12.9m

Compensación total

Porcentaje del salario del CEO7.6%
Permanencia del CEOless than a year
Participación del CEO0.003%
Permanencia media de la dirección5yrs
Promedio de permanencia en la Junta Directiva8.2yrs

Actualizaciones recientes de la dirección

Recent updates

When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?

Apr 29
When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?

Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Apr 15
Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear

Apr 01
Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear

Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Feb 21
Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)

Feb 14

Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Feb 08
Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly

Jan 28
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly

The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing

Jan 14
The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing

Edwards Lifesciences: Undervalued With A Substantial Upside Potential

Jan 09

Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Dec 31
Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Dec 17
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets

Oct 26

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Oct 23
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Oct 09
Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Sep 26
Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Sep 11
A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Rising Dominance In Structural Heart Disease

Aug 21

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Jul 16
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Jun 30
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Jun 15
Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed

Jun 12

Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

May 31
Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet

Apr 03
Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Mar 22
What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)

Mar 10
Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Feb 26
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges

Feb 06

Edwards Lifesciences slips as Piper downgrades on challenging setup

Jan 30

Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity

Jan 18

Edwards Lifesciences: Catalysts For 2023 And Beyond

Dec 30

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Dec 28
Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Dec 16
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences CEO Michael Mussallem to retire

Dec 08

Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Dec 04
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Bernard Zovighian en comparación con los beneficios de Edwards Lifesciences?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024n/an/a

US$1b

Dec 31 2023US$13mUS$973k

US$1b

Sep 30 2023n/an/a

US$1b

Jun 30 2023n/an/a

US$1b

Mar 31 2023n/an/a

US$1b

Dec 31 2022US$3mUS$642k

US$2b

Compensación vs. Mercado: La compensación total ($USD12.87M) de Bernard está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD13.51M).

Compensación vs. Ingresos: La compensación de Bernard ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.


CEO

Bernard Zovighian (55 yo)

less than a year

Permanencia

US$12,869,020

Compensación

Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Bernard Zovighian
CEO & Directorless than a yearUS$12.87m0.0030%
$ 1.6m
Scott Ullem
Corporate VP & CFO10.3yrsUS$5.95m0.044%
$ 22.9m
Donald Bobo
Corporate Vice President of Strategy & Corporate Development8.3yrsUS$4.29m0.033%
$ 17.3m
Larry Wood
Corporate VP and Group President of TAVR & Surgical Structural Heart1.3yrsUS$5.40m0.033%
$ 16.9m
Todd Brinton
Corporate VP of Advanced Technology & Chief Scientific Officer5.3yrssin datossin datos
Mark Wilterding
Vice President of Investor Relationsno datasin datossin datos
Arnold Pinkston
Corporate VP & General Counsel4.7yrssin datossin datos
Dirksen Lehman
Corporate Vice President of Public Affairs10.9yrssin datossin datos
Christine McCauley
Corporate Vice President of Human Resources11.8yrssin datossin datos
Gary Sorsher
Senior Vice President of Quality & Regulatory Complianceless than a yearsin datossin datos
Wayne Markowitz
GM & Senior VP of Surgical Structural Heartless than a yearsin datossin datos
Robert W. Sellers
VP & Corporate Controllerno datasin datos0.0049%
$ 2.6m

5.0yrs

Permanencia media

57.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de EW se considera experimentado (4.9 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Bernard Zovighian
CEO & Directorless than a yearUS$12.87m0.0030%
$ 1.6m
Kieran Gallahue
Independent Director9.3yrsUS$335.06k0.011%
$ 5.8m
Paul LaViolette
Independent Director3.8yrsUS$329.97k0.00082%
$ 424.2k
Michael Mussallem
Non-Executive Chairman of the Board24.3yrsUS$2.87m0.67%
$ 347.0m
Steven Loranger
Independent Director8.2yrsUS$335.06k0.011%
$ 5.8m
Leslie Heisz
Independent Director7.8yrsUS$356.42k0.0040%
$ 2.1m
Nicholas Valeriani
Independent Director9.5yrsUS$347.97k0.011%
$ 5.7m
Martha Marsh
Lead Independent Director8.6yrsUS$364.97k0.0048%
$ 2.5m
Ramona Sequeira
Independent Director4yrsUS$334.97k0.0014%
$ 703.5k

8.2yrs

Permanencia media

65yo

Promedio de edad

Junta con experiencia: La junta directiva de EW se considera experimentada (8.1 años de antigüedad promedio).